Price T Rowe Associates Inc. MD Sells 1,126,285 Shares of Docusign Inc. $DOCU

Key Points

• Price T Rowe Associates Inc. has reduced its position in Docusign Inc. by 26.2%, now holding approximately $257.63 million of the company's stock after selling over 1.1 million shares in the first quarter.
• Insider trading has seen significant activity, with CEO Allan C. Thygesen selling 40,000 shares, reducing his ownership by 21.74%, and CFO Blake Jeffrey Grayson also selling a portion of his shares.
• Docusign's quarterly earnings surpassed analysts' estimates, reporting earnings of $0.90 per share and revenue of $763.65 million, alongside the announcement of a $1 billion share buyback program.

Price T Rowe Associates Inc. MD lowered its holdings in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 26.2% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,164,961 shares of the company's stock after selling 1,126,285 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 1.56% of Docusign worth $257,629,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Hemington Wealth Management increased its position in shares of Docusign by 318.1% during the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after purchasing an additional 264 shares during the last quarter. Golden State Wealth Management LLC increased its position in shares of Docusign by 519.4% during the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after purchasing an additional 322 shares during the last quarter. Summit Securities Group LLC purchased a new stake in shares of Docusign during the 1st quarter valued at about $34,000. Wood Tarver Financial Group LLC purchased a new stake in shares of Docusign during the 4th quarter valued at about $37,000. Finally, MassMutual Private Wealth & Trust FSB increased its position in shares of Docusign by 153.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 453 shares of the company's stock valued at $37,000 after purchasing an additional 274 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company's stock.

Docusign Stock Performance

Shares of Docusign stock traded up $0.92 on Friday, hitting $76.43. 501,230 shares of the company traded hands, compared to its average volume of 2,557,105. The stock has a market capitalization of $15.44 billion, a P/E ratio of 14.43, a price-to-earnings-growth ratio of 27.87 and a beta of 1.01. Docusign Inc. has a 52 week low of $54.31 and a 52 week high of $107.86. The business has a 50-day simple moving average of $75.38 and a 200 day simple moving average of $79.87.

Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings data on Thursday, June 5th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.09. The firm had revenue of $763.65 million for the quarter, compared to analysts' expectations of $748.79 million. Docusign had a net margin of 36.50% and a return on equity of 14.27%. The company's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.82 earnings per share. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Research analysts expect that Docusign Inc. will post 1.17 earnings per share for the current year.

Docusign declared that its board has approved a share repurchase plan on Thursday, June 5th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the company to purchase up to 6.6% of its stock through open market purchases. Stock buyback plans are often a sign that the company's board believes its shares are undervalued.

Analysts Set New Price Targets

Several research firms have recently commented on DOCU. Bank of America reduced their price target on shares of Docusign from $88.00 to $85.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. Citigroup cut their price objective on Docusign from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Monday, June 9th. Robert W. Baird cut their price objective on Docusign from $93.00 to $85.00 and set a "neutral" rating for the company in a research note on Friday, June 6th. Wells Fargo & Company upgraded Docusign from an "underweight" rating to an "equal weight" rating and boosted their price objective for the company from $67.00 to $80.00 in a research note on Friday, June 13th. Finally, UBS Group cut their price objective on Docusign from $85.00 to $80.00 and set a "neutral" rating for the company in a research note on Friday, June 6th. Four equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $89.77.

Insider Transactions at Docusign

In other news, insider Robert Chatwani sold 22,875 shares of the stock in a transaction that occurred on Wednesday, June 18th. The stock was sold at an average price of $74.79, for a total transaction of $1,710,821.25. Following the completion of the transaction, the insider directly owned 72,126 shares in the company, valued at approximately $5,394,303.54. This represents a 24.08% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $74.37, for a total value of $39,713.58. Following the transaction, the director owned 8,805 shares of the company's stock, valued at $654,827.85. This represents a 5.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 78,552 shares of company stock valued at $5,983,631 over the last quarter. 1.01% of the stock is owned by insiders.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.